none | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.
MENU

All posts in none

October 5, 2021
UPDATE TO OUR COVID-19 POLICY

Dear Friends and Colleagues,

We are looking forward to our upcoming peptide symposium in Boulder and having an opportunity to greet many of you in person. In order to enhance the safety of all our visitors the organizers have finalized a COVID policy for all guests.

As part of this policy, proof of COVID-19 vaccination is required to attend the symposium in person. This information will be required at time of check in and can be in the form of a government issued vaccination card, mobile app, or image of paper documentation. Individuals who are not vaccinated, even for religious or medical reasons, will not be allowed to attend the symposium.

Read the Full Policy Here

BPS News, News, none Comments Off on UPDATE TO OUR COVID-19 POLICY
October 5, 2021
Acrotein

ACROTEIN WEBSITE

Company

Founded in 2011, Acrotein Chembio Inc. is a leading supplier and manufacturer of research chemicals to pharmaceutical / biotech companies, universities and contract research organizations etcAcrotein Chembio Inc. is headquartered in AL, USA. We are serving the customers worldwide with over 8000+ compounds in stock. Besides catalog products, our services include custom synthesis of novel building blocks, reference standard compounds, and bioactive compounds & natural Products, bulk manufacturing, sourcing and procurement.

With the experienced chemists and state-of-the-art equipment, such as Bruker 400M NMR, LC-MS, HPLC ect., Acrotein Chembio possesses the powerful R&D capability for novel products, and assurance of high product quality.

Acrotein Chembio Inc.has presented a wide range of products and synthesis services to over 1500 customers worldwide. Because of timely delivery, competitive price, and high product quality, Acrotein Chembio has established good cooperation with distinguished pharmaceutical companies/institutes all over the world.

CONTACT

Acrotein Chembio, Inc.

location_on 2194 Suite K, Riverchase Business Park, Parkway Lake Drive, Hoover, AL 35244 USA

local_phone(205)730-9388contact_mail sales@acrotein.com

Active Sponsors, none, Sponsors Comments Off on Acrotein
October 5, 2021
Biosynth

Company

Securing Life Sciences Supply Chains - where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, we are science-led and customer-focused to solve problems, taking pride in delivering products and projects that others cannot.

Our expertise and capabilities run across Complex Chemicals, Peptides and Key Biologics, all from one trusted partner. Supplying the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network.

Biosynth is showcasing its offering across the full range of peptide products and services. From custom peptide synthesis and library production, lead discovery and optimization, large scale peptide manufacture and GMP compliant NCEs, neoantigen peptides.

We are experienced in targeted nuclear medicine, both in diagnostic imaging and therapy as well as theranostics. Peptides play an important role in this field as they can specifically deliver both radioactive markers and therapies to a tumor.

Biosynth offers a unique CLIPS™ phage display platform to discover highly constrained de novo peptides with enhanced affinity against your target of interest, selectivity, and proteolytic stability. Come and talk to the Biosynth team if you want to know how we can assist you in progressing your peptide project through (pre-) clinical development, application, and commercialization. www.biosynth.com

CONTACT

Biosynth

location_on65 Zub Lane, Gardner, MA 01440

local_phone1-978-630-0020

local_phone888-343-5974

contact_mailpeptides@biosynth.com

none Comments Off on Biosynth
May 5, 2021
Longtime Friend and Scientific Contributor to the Boulder Peptide Symposium, Dr. Robert Hodges, Passed Away in April 2021

Dr. Hodges was a fixture at many of our symposia, both as an attendee and presenter. Most recently at BPS 2019, Dr. Hodges presented "On the Road to Commercialization of Antimicrobial Peptides to Treat Gram-Negative Bacterial Infections," during the Peptide Showcase.

Dr. Hodges was professor of biochemistry & molecular genetics and chair in peptide chemistry at the University of Colorado. During his career, he has been awarded the R. Bruce Merrifield Award (2017), the Murray Goodman Scientific Excellence & Mentorship Award (2013), and the Vincent du Vigneaud Award (2004) among others. Dr. Hodges was also active in the American Peptide Society, serving as president from 1997 - 1999.

Our sincere condolences go out to Dr. Hodges' family, friends, and colleagues. He will be sorely missed at our future gatherings. More about Dr. Hodges's career and achievements can be found at https://www.americanpeptidesociety.org/obituary/hodges-robert/

none Comments Off on Longtime Friend and Scientific Contributor to the Boulder Peptide Symposium, Dr. Robert Hodges, Passed Away in April 2021
July 18, 2018
cerapedics logo
Orthobiologics Company Cerapedics Closes $22M Financing
Published on 

Cerapedics, a Westminster, Colo.-based orthobiologics company, completed a $22m financing.

The round was led by KCK Group.

The company intends to use the funds to accelerate commercialization and U.S. lumbar trial for i-FACTOR™ Peptide Enhanced Bone Graft.

Led by Glen A. Kashuba, chief executive officer, Cerapedics is an orthobiologics company focused on developing and commercializing its proprietary biomimetic small peptide (P-15) technology platform. i‑FACTOR Peptide Enhanced Bone Graft is a biologic bone that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process.
The company received Premarket Approval (PMA) from the U.S. Food & Drug Administration for the use of i-FACTOR Peptide Enhanced Bone Graft in anterior cervical discectomy and fusion (ACDF) procedures. It has also initiated an IDE clinical trial in transforaminal lumbar interbody fusion (TLIF) surgery.

In addition, Cerapedics also announced three new members of the company’s board of directors, including:
– Valeska Schroeder, Ph.D., managing director of the medical technologies division at KCK Group,
– Greg Garfield, J.D., senior managing director and head of the medical technologies division at KCK Group, and
– Nael Karim Kassar, investment partner at KCK Group.

none Comments Off on Orthobiologics Company Cerapedics Closes $22M Financing
June 11, 2018
Phenomenex
none Comments Off on Phenomenex
September 28, 2017
test

[RegButton code="bps2018" image="http://boulderpeptide.org/wp-content/uploads/2015/03/Pharma.png" rate1="800" rate2="600" rate3="400"  date1="2017-09-01" date2="2017-10-04" date3="2017-10-11"]

[RegButton code="bps2018" image="http://boulderpeptide.org/wp-content/uploads/2015/03/Pharma.png" rate1="800" rate2="600"  rate3="400"  date1="2017-09-01" date2="2017-09-24" date3="2017-10-11"]

 

none Comments Off on test
July 25, 2017
Corden Pharma

CordenPharma is the CDMO partner you need for small to large-scale peptide development and manufacturing. As a result of increasing demand in the GLP-1 medications market, our recently announced peptide initiatives include significant expansions in CordenPharma Colorado (US) and a new greenfield site to be constructed in Switzerland, both designed according to the pharmaceutical industry’s most stringent quality and technical standards for short and long peptide manufacturing, including BLA requirements.

With a passionate team of scientific experts, we leverage decades of experience in providing innovators with complex modalities across our Peptide, Oligonucleotide, and Lipids platforms, seamlessly integrated with bespoke LNP formulation and Injectable manufacturing to secure your supply chain at any scale. https://cordenpharma.com/

none Comments Off on Corden Pharma
April 18, 2017
TBi Beta Site Changes 4/17 – Testing for live upload

1. .htaccess replace the content Line 10 - 96
2. /wp-content/themes/bpscustomization/buddypress/assets/emails/single-bp-email.php Added the single-bp-email.php file to create shortcode

3. Created 2 short codes in admin section Settings > Shortcoder
i)

Boulder Peptide Society


ii)

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

4. For home page Remove the YouTube widgets to speed site up:
i) In Main Sidebar => Huge IT Slider: Young Investigator Award 2016
ii) Footer Left Column => Huge IT Slider: BPS 2016

none Comments Off on TBi Beta Site Changes 4/17 – Testing for live upload
January 26, 2017
Password Reset Link Missing:fixed

WordPress default password reset email has a formatting issue where the link gets dropped in the email message. This was fixed by adding a password email hook in functions.php as:

add_filter('retrieve_password_message', 'password_reset_message', 10, 3);
function password_reset_message($message, $reset_key, $userlogin)
{
$message .= 'RESET (' . network_site_url('wp-login.php?action=rp&key=' . $reset_key . '&login=' . rawurlencode($userlogin), 'login') . ')';
return $message;
}

none Comments Off on Password Reset Link Missing:fixed
Older Entries
Newer Entries

Email

support@boulderpeptide.org

s2Member®
loading...